Member Info for GordonGecko123

I see tg2d has gone quiet. What a surprise when they get it wrong they disappear. Happens everytime. At least when I get it wrong I say fair enough but there are to many who's can't admit they are wrong on these boards

the management have been the problem for a while now and one of the reasons i have been so negative on agl. takes a bull**** yer to spot one and seems many don't have that ability and believed the blue sky soundbites from. management. last chance saloon now somrhting has to give wether this is an retiring, fund raise or sale

Is it? Doesn't seem so. More garbage from you as usual

Coming from you that is. A total joke. The one who posted several times a day for months slating the company none stop only to change their tune totally after you bought in. A

I have been on these boards for decades and my view on angle has been consistent throughout. Many don't like it and have tried to talk me down over the years but the proof is in the sp.

This has been a spectacular failure that is running out of time very quickly now.

Personally I don't care what you have to say as it's the same repetitive diatrite and wishful thinking that's been spewed out by mnay investors for years but has led to absolutely nothing of value.

I've dealt with far more intelligent oeople than you over those decades and probably forgot more than you will ever know about this company.

The cats are running out of cash, loss making heavily and unable to secure major contracts with big pharma. No matter how much waffle you continue to post those are facts. Many mistakes have been made and oc tinue to be made here hence it's under 6p and with a chart that looks dire to say the least.

Nothing from AN recently has been positive, even he seems to finally realise it's not going to work out as he thought. The silence is both worrying and telling from hq.

Chmaces of a major deal before October are about 5% imo and that's the gamble if the cash will. Last that long which is up for debate. Losing 1.2m a month and going off the last financial position makes that look to be the latest they will manage to drag this out imo.

Yes they might sign something but unless it's truly massive it won't help them much as the sp tends to spike and fall back very quickly after limiting chmaces of a raise at a higher price.

Like I keep saying time is running out

Let's be honest so far pharma services is also turning out to be a total flop. Revveues have failed to grow and the lack of deals is alarming yet again. No matter how good parsortix may be it's no good if they can't sell it to their potential customers for whatever reason. Is it cost, saving money, not suitable? Whatever the reason is customers are not taking it on and in that case agl is doomed.

With the current situation they don't have time or money to play with and unless something truly monumental comes in the next few months @the possible outcomes after all look grim to say the least.

Like many companies the transition from research and development to sales is one not many manage. Too many mistakes made here and without a seriously huge rbabot out the hat in the coming months the writing is on the wall.

A lot of long time holders have sold up or reduced recently, even those that were huge AN fans, shows how bD things actually look for the near future

Doesn't look good as the cash runs out the sp continues to fall and nothing from the company. Sometimes you just have to realise it isn't going to happen. To pull out a major deal looks less and less likely and they need money very soon. Seems all the promise is going to go to waste here due to poor management imo

Excellent point I made many years ago. It's about money and saving money isn't the name of the game I'm afraid. The best route is as a companion diagnostic or in drug development but they have been unable to get anywhere with those either.

Niche market at best for parsortix imo

Should have done this years ago. The fact that nearly all patients have never even heard of parsortix and the same story with doctors and oncologists in hospitals says it all.

They have grossly underestimated the time it takes and likely to mean this will run out of cash or he diluted so much it owmt make investors any money shows how poorly it's been managed.

AN is coming to retirement age if not already there but he won't let it go so it will either succeed or fail miserably and he retires. Odds are highly stacked on the latter

Very true post.. If the benefits are so good they would be climbing over themselves to get angle.. The reality is they aren't and with so many other avenues possible these days angle are fast losing their advantage. They made the mistake years ago not partnering with a bigger company so it was incorporated into their trials. AN preferring to go it alone thinking they would clean up once they got fda. All. That proved was he didn't research and talk to his market where he would have found out they wanted something very different to what he had planned. That wasted 3 years trying to find a path to market which should have been identified while awaiting fda approval.

Spending 1.2-2m a month on what?. They should have slashed the costs after fda as sok as they realised the big offers were not coming. They continue to spend a whopping 1.2m a month whilst delivering no contrcats or revveue growth.

Last chance saloon here either a big service contract comes or it's the dreaded death spiral funding imo

They have had hundreds of such papers and posters but they are not leading to any big money spinning contrcats. Same old story here something that should be making the firm millions isn't making them hardly anything even after years of trying and changing different options.

Until this happens this is just kicking the can down the road and in the meantime wasting millions. 1.2m a month for less than 250k a month in revenues. Great business this is

There was a 3m rollover or isa swap which was 6m.om the sell side so today we have actually had more buys than sells and mms extracting the urine as always..Hopefully some news soon on ffs work and increased revenues would see this move again. Be nice to see it break the 0. 5p and hopefully then news on Unilever in Q4 or AZ

And yet it's down again.. Doesn't say mucb with all these people saying how good parsortix is that AN can't seem to sell it to anyone.

Something very wrong here and with this company. Such promise and fails to deliver

Timing doesn't relaly matter, what matters is th epeopel interested in apta and the things they are doing. With 15 of the top pharma companies signing up and with several projects in the latter stages the point of transformative deals is closer than ever.

The board are highly energised and set the share options so they deliver both for themselves and shareholders.

As this becomes obvious it's in demand and hugely helpful to companies someone will look to buy this before their competitors do imo

They were sells, a long term holder sold the lot of his holding today after being fed up and seeing the chances slip away here.

The Placing significantly strengthens Aptamer Group's balance sheet, substantially enhancing credibility and supporting due diligence

That says what we are thinking imo

Bob I totally agree with your thinking here and what Aaron has basically said. Unilever would be concerned about ability to scale up and deliver on signing a licensing deal. And would want assurances.. I believe that contrcats are now going to be signed and we will get a lot of very positive news that will drive the sp higher. Raising also serves to underpin the sp on the way up.

Https://www.abcmoney.co.uk/2025/07/gsk-strengthens-uk-biotech-with-major-rd-investment/

I wonder if they are taking to these now. They should be

Only line that matters. Licensing deals imminent!!!!!!

Now I want to see increased revenues pretty soon. Some FFS contracts to narrow the gap to break even before end of the year.

We should get news on Unilever in the next few months. Q4 they said. That's the big one

It underpins the price at 0.3p that's the good news and allows them more time for revenues to kick in